LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Scott will join a panel discussion focusing on raising US venture capital at the BioFinance 2012 conference in Toronto on May 29-30, 2012
News | 05. 14. 2012
Scott will sit on a panel focusing on raising US venture capital at the BioFinance 2012 conference in Toronto on May 29-30, 2012
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.